Repurposing of FDA Approved Alkaloids as COVID 19 Inhibitors; in silico Studies

ArticleView

Images

Graphical Abstract

Cite This Article

Vancouver Style ::
Mostafa EM, Gamal M, Ghoneim MM, Hussein S, El-Ghorab AH, Abdelgawad MA, et al. Repurposing of FDA Approved Alkaloids as COVID 19 Inhibitors; in silico Studies. Pharmacognosy Journal. 2021;13(1):110-123.PDF icon PDF (6.7 MB)